Literature DB >> 15040561

Post-injury malaria: a risk factor for wound infection and protracted recovery.

Mads Sundet1, Tove Heger, Hans Husum.   

Abstract

OBJECTIVE: To assess the impact of post-injury falciparum malaria on morbidity parameters in Cambodia.
METHOD: Retrospective study of 227 trauma patients managed at a surgical centre in Battambang, Cambodia.
RESULTS: Within 10 days of the injury, 42.7% of the study population developed symptomatic malaria. In patients with post-injury malaria, the rate of wound infection was 36.1% compared with 10.0% in patients without symptomatic malaria (95% confidence interval for difference 15.2-36.9%). The average hospital stay in the post-injury malaria group was 31.2 days compared with 19.4 days in the patients without the complication (95% confidence interval for difference 7.2-16.4 days).
CONCLUSION: Symptomatic malaria after trauma is common in Cambodia. Post-injury malaria seems to increase the risk of wound infection, delays postoperative recovery, and thus adds to the burden of trauma.

Entities:  

Mesh:

Year:  2004        PMID: 15040561     DOI: 10.1046/j.1365-3156.2003.01190.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  3 in total

1.  Malaria Relapses Following Parasite-Free Blood Transfusions in the U.S. Army during the Korean War.

Authors:  G Dennis Shanks; Michael Waller
Journal:  Am J Trop Med Hyg       Date:  2022-02-28       Impact factor: 2.345

2.  Preoperative Anaemia and Associated Postoperative Outcomes in Noncardiac Surgery Patients in Central Region of Ghana.

Authors:  Gladys Amponsah; Alice Charwudzi
Journal:  Anesthesiol Res Pract       Date:  2017-12-11

3.  Predictors of Poor Postoperative Outcomes in Pediatric Surgery Patients in Rural Ghana.

Authors:  Sarah Peiffer; Anna E Ssentongo; Laura Keeney; Forster Amponsah-Manu; Richard Yeboako; Richard Ofosu-Akromah; Temitope Ebenezer Arkorful; Eric Agyemang; Anthony Tsai; John Oh; Paddy Ssentongo
Journal:  BMC Surg       Date:  2020-09-22       Impact factor: 2.102

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.